On October 31,‍ JPMorgan low‍ered its price target on GSK plc (NYSE:GSK) to 1,440 GBp fro⁠m 1,550 GBp w⁠hile maintaining an ...

The stock market environment isn't as good as implied by the “regular new highs” booked by the S&P 500 index, as enthusiasm for artificial intelligence has helped investors ignore “tariff chaos,” the ...

Trevi Therapeutics is developing nalbuphine ER (Haduvio) for chronic cough in IPF and RCC, targeting unmet medical needs.

A strong performer already, GSK stock is trading up 44% in 2025, yet its stock remains a good bargain. GSK trades for a ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has announced the repurchase of 167,000 of its own shares as part of its ongoing ...

GSK plc (NYSE: GSK) is one of the best undervalued stocks to buy under $50. Deutsche Bank analyst Emmanuel Papadakis released ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GlaxoSmithKline (GSK) has announced a recent purchase of 170,000 of its own ordinary shares ...

About Palo Alto Networks Inc. Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the ...

GSK PLC's (NYSE: GSK) short interest as a percent of float has risen 6.45% since its last report. According to exchange reported data, there are now 13.33 million shares sold short, which is 0.66% of ...

Learn more about whether Arrowhead Pharmaceuticals, Inc. or BioMarin Pharmaceutical Inc. is a better investment based on AAII ...

Learn more about whether BioMarin Pharmaceutical Inc. or Amicus Therapeutics, Inc. is a better investment based on AAII's A+ ...

India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for ...